We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A severe case of bevacizumab-induced thrombotic microangiopathy.
- Authors
Bektas, Mert; Samancı, Nilay S; Cokgezer, Simay; Keskin, Dilek; Demirelli, Fuat H
- Abstract
Bevacizumab is a human monoclonal antibody against VEGF. Many adverse reactions about bevacizumab are identified including venous and arterial thromboembolism, nausea, fatigue, alopecia, proteinuria, gastrointestinal system (GIS) perforation, exfoliative dermatitis, and peripheral edema and thrombocytopenia. In this paper, we report a case of bevacizumab-induced dose-dependent, toxicity-mediated drug-induced thrombotic microangiopathy.
- Subjects
BALDNESS; EDEMA; FATIGUE (Physiology); GASTROINTESTINAL system; NAUSEA; PROTEINURIA; THROMBOEMBOLISM; THROMBOTIC microangiopathies; VEINS; BEVACIZUMAB; EXFOLIATIVE dermatitis
- Publication
Journal of Oncology Pharmacy Practice, 2019, Vol 25, Issue 7, p1754
- ISSN
1078-1552
- Publication type
Article
- DOI
10.1177/1078155218800371